Feb 17, 2022 / 03:00PM GMT
Marc Harold Goodman - SVB Leerink LLC, Research Division - Senior MD of Neuroscience & Senior Research Analyst
Thanks. Good morning, everybody. Welcome back to the SVB Leerink Healthcare Conference. I'm Marc Goodman, one of the biopharma analysts, and we have up for our next session, Karuna Therapeutics, which is a company in the CNS space, that I don't cover, but we've been following pretty closely for the past couple of years and has had a lot of success. Obviously, the next year is a very important time for the company. And Andrew Miller, who's the Founder and Chief Operating Officer of Karuna, is here, and he's going to go through a presentation, and then we'll have some Q&A after that.
And so Andrew, I'll give it to you to take it away. Thanks.
Andrew Craig Miller - Karuna Therapeutics, Inc. - Co-Founder & COO
Great. Thanks, Marc. I appreciate the invitation to present and always look forward to the opportunity to kind of tell our story a little bit. So with that, I'll jump right into it. Of course, starting out with standard disclosure
Karuna Therapeutics Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers